Diploma PLC (LON:DPLM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is GBX 6,251.25.
Several brokerages recently issued reports on DPLM. Berenberg Bank lifted their target price on Diploma from GBX 6,600 to GBX 7,500 and gave the company a “buy” rating in a research report on Thursday, March 19th. Shore Capital Group reaffirmed a “hold” rating on shares of Diploma in a research report on Wednesday, March 18th. Royal Bank Of Canada lifted their target price on Diploma from GBX 6,200 to GBX 6,600 and gave the company an “outperform” rating in a research report on Thursday, March 19th. Deutsche Bank Aktiengesellschaft lifted their target price on Diploma from GBX 6,200 to GBX 6,400 and gave the company a “buy” rating in a research report on Thursday, March 19th. Finally, Jefferies Financial Group lifted their target price on Diploma from GBX 5,200 to GBX 5,700 and gave the company a “hold” rating in a research report on Monday, March 23rd.
Get Our Latest Stock Analysis on DPLM
Insider Activity
Diploma Stock Down 2.4%
Shares of LON:DPLM opened at GBX 6,689.42 on Friday. The stock has a market cap of £8.97 billion, a price-to-earnings ratio of 48.72, a PEG ratio of 2.82 and a beta of 0.92. The company has a quick ratio of 0.80, a current ratio of 2.04 and a debt-to-equity ratio of 46.97. Diploma has a 12-month low of GBX 4,146 and a 12-month high of GBX 7,295. The business’s 50 day moving average is GBX 6,278.03 and its 200 day moving average is GBX 5,741.33.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
- Five stocks we like better than Diploma
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
